合計 50 件の最近のインサイダー取引記録が記録されています Cardiff Oncology, Inc. (CRDF), 内訳は 47 件の買い および 1 件の売り. インサイダー買い総額は $16.4M インサイダー売り総額は $743.75K.
最近活動のある主要インサイダーには Mohindru Mani, Lindsay Brigitte Ute, Pace Gary W. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — CRDF
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-03-31 |
Mohindru Mani |
Chief Executive Officer |
RSU 付与（制限付株式） |
600,000 |
$1.62 |
$972K |
968,766 |
| 2026-02-17 |
Mohindru Mani |
Interim CEO |
RSU 付与（制限付株式） |
200,000 |
$1.56 |
$312K |
368,766 |
| 2026-02-13 |
Lindsay Brigitte Ute |
Chief Accounting Officer |
RSU 付与（制限付株式） |
200,000 |
$1.60 |
$320K |
1,025,334 |
| 2026-01-27 |
Lindsay Brigitte Ute |
Chief Accounting Officer |
不明 |
166,320 |
$3.58 |
$595.43K |
- |
| 2025-07-30 |
Pace Gary W |
Director |
情報に基づく買い |
275,000 |
$2.45 |
$673.75K |
1,330,676 |
| 2025-06-26 |
Pace Gary W |
Director |
RSU 付与（制限付株式） |
40,565 |
$3.16 |
$128.19K |
187,539 |
| 2025-06-26 |
Armitage James O |
Director |
RSU 付与（制限付株式） |
40,565 |
$3.16 |
$128.19K |
187,539 |
| 2025-06-26 |
White Lale |
Director |
RSU 付与（制限付株式） |
40,565 |
$3.16 |
$128.19K |
158,681 |
| 2025-06-26 |
Markin Rodney S |
Director |
RSU 付与（制限付株式） |
40,565 |
$3.16 |
$128.19K |
222,865 |
| 2025-06-26 |
Tannenbaum Renee P |
Director |
RSU 付与（制限付株式） |
40,565 |
$3.16 |
$128.19K |
168,766 |
| 2025-06-26 |
Mohindru Mani |
Director |
RSU 付与（制限付株式） |
40,565 |
$3.16 |
$128.19K |
168,766 |
| 2025-06-16 |
Sidhu Roger |
Chief Medical Officer |
不明 |
600,000 |
$3.86 |
$2.32M |
- |
| 2025-03-11 |
Levine James E. |
Chief Financial Officer |
RSU 付与（制限付株式） |
332,621 |
$3.58 |
$1.19M |
1,295,117 |
| 2025-03-11 |
Erlander Mark |
Chief Executive Officer |
RSU 付与（制限付株式） |
758,400 |
$3.58 |
$2.72M |
2,925,098 |
| 2025-03-11 |
Kabbinavar Fairooz |
Chief Medical Officer |
RSU 付与（制限付株式） |
150,000 |
$3.58 |
$537K |
780,008 |
| 2025-03-11 |
Smeal Tod |
Chief Scientific Officer |
RSU 付与（制限付株式） |
332,621 |
$3.58 |
$1.19M |
979,805 |
| 2024-12-18 |
Levine James E. |
Chief Financial Officer |
情報に基づく買い |
2,400 |
$5.00 |
$12K |
67,716 |
| 2024-12-17 |
Levine James E. |
Chief Financial Officer |
情報に基づく買い |
2,752 |
$5.42 |
$14.91K |
65,316 |
| 2024-12-16 |
Levine James E. |
Chief Financial Officer |
情報に基づく買い |
2,564 |
$3.83 |
$9.82K |
62,564 |
| 2024-12-12 |
Tannenbaum Renee P |
Director |
情報に基づく買い |
10,000 |
$3.42 |
$34.22K |
20,000 |
| 2024-12-11 |
Pace Gary W |
Director |
情報に基づく買い |
350,115 |
$2.60 |
$910.3K |
1,047,876 |
| 2024-06-27 |
Pace Gary W |
Director |
RSU 付与（制限付株式） |
29,700 |
$2.33 |
$69.2K |
146,974 |
| 2024-06-27 |
Armitage James O |
Director |
RSU 付与（制限付株式） |
29,700 |
$2.33 |
$69.2K |
146,974 |
| 2024-06-27 |
Markin Rodney S |
Director |
RSU 付与（制限付株式） |
29,700 |
$2.33 |
$69.2K |
182,027 |
| 2024-06-27 |
Tannenbaum Renee P |
Director |
RSU 付与（制限付株式） |
29,700 |
$2.33 |
$69.2K |
128,201 |
| 2024-06-27 |
White Lale |
Director |
RSU 付与（制限付株式） |
29,700 |
$2.33 |
$69.2K |
146,974 |
| 2024-06-27 |
Mohindru Mani |
Director |
RSU 付与（制限付株式） |
29,700 |
$2.33 |
$69.2K |
128,201 |
| 2024-03-07 |
Levine James E. |
Chief Financial Officer |
RSU 付与（制限付株式） |
205,008 |
$3.51 |
$719.58K |
962,496 |
| 2024-03-07 |
Erlander Mark |
Chief Executive Officer |
RSU 付与（制限付株式） |
510,000 |
$3.51 |
$1.79M |
2,170,310 |
| 2024-03-07 |
Kabbinavar Fairooz |
Chief Medical Officer |
RSU 付与（制限付株式） |
205,008 |
$3.51 |
$719.58K |
630,008 |
| 2024-03-07 |
Smeal Tod |
Chief Scientific Officer |
RSU 付与（制限付株式） |
205,008 |
$3.51 |
$719.58K |
647,184 |
| 2023-12-19 |
Pace Gary W |
Director |
情報に基づく買い |
30,000 |
$1.37 |
$41.1K |
697,761 |
| 2023-11-10 |
Pace Gary W |
Director |
情報に基づく買い |
22,950 |
$0.98 |
$22.49K |
667,761 |
| 2023-06-15 |
Pace Gary W |
Director |
RSU 付与（制限付株式） |
27,700 |
$1.59 |
$44.04K |
117,274 |
| 2023-06-15 |
Armitage James O |
Director |
RSU 付与（制限付株式） |
27,700 |
$1.59 |
$44.04K |
117,274 |
| 2023-06-15 |
Markin Rodney S |
Director |
RSU 付与（制限付株式） |
27,700 |
$1.59 |
$44.04K |
152,327 |
| 2023-06-15 |
Tannenbaum Renee P |
Director |
RSU 付与（制限付株式） |
27,700 |
$1.59 |
$44.04K |
98,501 |
| 2023-06-15 |
White Lale |
Director |
RSU 付与（制限付株式） |
27,700 |
$1.59 |
$44.04K |
117,274 |
| 2023-06-15 |
Mohindru Mani |
Director |
RSU 付与（制限付株式） |
27,700 |
$1.59 |
$44.04K |
98,501 |
| 2023-03-15 |
Levine James E. |
Chief Financial Officer |
RSU 付与（制限付株式） |
197,472 |
$1.72 |
$339.65K |
757,488 |
| 2023-03-15 |
Erlander Mark |
Chief Executive Officer |
RSU 付与（制限付株式） |
482,064 |
$1.72 |
$829.15K |
1,664,477 |
| 2023-03-15 |
Kelemen Vicki |
Exec. VP and COO |
RSU 付与（制限付株式） |
125,520 |
$1.72 |
$215.89K |
698,304 |
| 2023-03-15 |
Smeal Tod |
Chief Scientific Officer |
RSU 付与（制限付株式） |
167,088 |
$1.72 |
$287.39K |
442,176 |
| 2023-01-30 |
Kabbinavar Fairooz |
Chief Medical Officer |
処分 |
425,000 |
$1.75 |
$743.75K |
- |
| 2022-11-25 |
Erlander Mark |
Chief Executive Officer |
情報に基づく買い |
10,000 |
$1.43 |
$14.3K |
24,481 |
| 2022-09-19 |
White Lale |
Director |
情報に基づく買い |
15,000 |
$1.64 |
$24.53K |
113,788 |
| 2022-09-16 |
Levine James E. |
Chief Financial Officer |
情報に基づく買い |
30,000 |
$1.56 |
$46.71K |
60,000 |
| 2022-09-16 |
Armitage James O |
Director |
情報に基づく買い |
13,000 |
$1.56 |
$20.23K |
13,000 |
| 2022-09-15 |
Pace Gary W |
Director |
情報に基づく買い |
150,000 |
$1.71 |
$256.5K |
644,811 |
| 2022-09-15 |
Tannenbaum Renee P |
Director |
情報に基づく買い |
6,400 |
$1.72 |
$10.98K |
6,400 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
